Beijing Balance Medical Technology Co Ltd
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patch… Read more
Market Cap & Net Worth: Beijing Balance Medical Technology Co Ltd (688198)
Beijing Balance Medical Technology Co Ltd (SHG:688198) has a market capitalization of $1.90 Billion (CN¥13.97 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #9220 globally and #1863 in its home market, demonstrating a 0.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Balance Medical Technology Co Ltd's stock price CN¥101.39 by its total outstanding shares 137748133 (137.75 Million).
Beijing Balance Medical Technology Co Ltd Market Cap History: 2019 to 2026
Beijing Balance Medical Technology Co Ltd's market capitalization history from 2019 to 2026. Data shows growth from $558.84 Million to $1.90 Billion (25.06% CAGR).
Beijing Balance Medical Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Balance Medical Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.08x
Beijing Balance Medical Technology Co Ltd's market cap is 4.08 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
13.99x
Beijing Balance Medical Technology Co Ltd's market cap is 13.99 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $558.84 Million | $146.03 Million | $63.08 Million | 3.83x | 8.86x |
| 2020 | $1.03 Billion | $181.92 Million | $56.53 Million | 5.67x | 18.24x |
| 2021 | $3.38 Billion | $251.82 Million | $51.20 Million | 13.43x | 66.03x |
| 2022 | $2.41 Billion | $295.17 Million | $95.14 Million | 8.17x | 25.34x |
| 2023 | $2.34 Billion | $370.64 Million | $115.21 Million | 6.31x | 20.29x |
| 2024 | $2.05 Billion | $501.88 Million | $146.33 Million | 4.08x | 13.99x |
Competitor Companies of 688198 by Market Capitalization
Companies near Beijing Balance Medical Technology Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Beijing Balance Medical Technology Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Beijing Balance Medical Technology Co Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, Beijing Balance Medical Technology Co Ltd's market cap moved from $558.84 Million to $ 1.90 Billion, with a yearly change of 25.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.90 Billion | -5.25% |
| 2025 | CN¥2.01 Billion | -1.83% |
| 2024 | CN¥2.05 Billion | -12.46% |
| 2023 | CN¥2.34 Billion | -3.03% |
| 2022 | CN¥2.41 Billion | -28.69% |
| 2021 | CN¥3.38 Billion | +227.83% |
| 2020 | CN¥1.03 Billion | +84.54% |
| 2019 | CN¥558.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Beijing Balance Medical Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.90 Billion USD |
| MoneyControl | $1.90 Billion USD |
| MarketWatch | $1.90 Billion USD |
| marketcap.company | $1.90 Billion USD |
| Reuters | $1.90 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.